Scholarlink

Objective <p>This study aims to assess depressive and anxiety symptoms as well as somatosensory amplification tendency in patients with polycystic ovary syndrome (PCOS) and to analyze their scale scores.</p> Material and methods <p>This study included 140 women aged 18–45, comprising 70 diagnosed with PCOS and 70 healthy controls. Patients with PCOS were assessed for using the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), The Somatosensory Amplification Scale (SSAS), and Health Anxiety Inventory (HAI) questionnaires.</p> Results <p>In comparison to the control group, the PCOS group exhibited substantially higher mean scores on the Somatosensory Amplification Scale (SSAS), Health Anxiety Inventory (HAI), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI) (<i>p</i> &lt; 0.001). The PCOS patients in our research had mean BAI scores of 19.6, mean BDI scores of 14.7, mean SSAS scores of 32.6, and mean HAI scores of 18.7.</p> Conclusions <p>In our study, PCOS patients scored higher on measures of somatosensory amplification, depressive, and anxiety symptoms than the control group. We wish to underline the need for timely psychological assessment and support for individuals diagnosed with PCOS. Consequently, we believe that early identification and management of psychological distress will reduce the need for recurrent medical care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Somatosensory Amplification, Health Anxiety, and Depression in Polycystic Ovary Syndrome Patients

  • 期刊论文

  • 发表日期：

    2025年4月10日

查看全文
  • Büşra Çetintulum Aydın,
  • Elif Turan,
  • Özgül Karaaslan,
  • Betül Çetintulum Huyut,
  • Süleyman Baş

摘要

Objective

This study aims to assess depressive and anxiety symptoms as well as somatosensory amplification tendency in patients with polycystic ovary syndrome (PCOS) and to analyze their scale scores.

Material and methods

This study included 140 women aged 18–45, comprising 70 diagnosed with PCOS and 70 healthy controls. Patients with PCOS were assessed for using the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), The Somatosensory Amplification Scale (SSAS), and Health Anxiety Inventory (HAI) questionnaires.

Results

In comparison to the control group, the PCOS group exhibited substantially higher mean scores on the Somatosensory Amplification Scale (SSAS), Health Anxiety Inventory (HAI), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI) (p < 0.001). The PCOS patients in our research had mean BAI scores of 19.6, mean BDI scores of 14.7, mean SSAS scores of 32.6, and mean HAI scores of 18.7.

Conclusions

In our study, PCOS patients scored higher on measures of somatosensory amplification, depressive, and anxiety symptoms than the control group. We wish to underline the need for timely psychological assessment and support for individuals diagnosed with PCOS. Consequently, we believe that early identification and management of psychological distress will reduce the need for recurrent medical care.